Around the world, a renewed focus on rare diseases and orphan drugs is beginning to move the needle – but there is more work to do.
Experts from the World Orphan Drug Congress USA 2022 discuss the factors enabling better research and development of rare disease drugs, and what can be done to improve the field in the future.